ONCY Oncolytics Biotech Inc.

Fundamentals / CIK 0001129928 / USD

Oncolytics Biotech Inc. reported $5.83M in total assets and a net loss of $37.28M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ONCY in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

2 fiscal years (2024 to 2025), reported in USD.

$0$0$0-$26.89MFY 2024 Net Income: -$22.79M2024FY 2025 Net Income: -$28.76M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31
Research & Development $13.31M $15.44M
Total Operating Expenses $28.73M $25.54M
Operating Income -$28.73M -$25.54M
EBITDA -$28.66M -$25.45M
Interest Income $386K $975K
Income Before Tax -$28.68M -$22.70M
Income Tax Expense $79K $95K
Net Income -$28.76M -$22.79M
Basic EPS -$0.30 -$0.30
Diluted EPS -$0.30 -$0.30
Basic Shares Outstanding 95.9M 76.5M
Diluted Shares Outstanding 95.9M 76.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Research & Development $5.15M $4.26M $4.55M $3.52M $5.08M $1.92M $2.80M
Total Operating Expenses $9.74M $9.38M $9.28M $9.49M $9.56M $4.65M $5.02M
Operating Income -$9.74M -$9.38M -$9.28M -$9.49M -$9.56M -$4.65M -$5.02M
EBITDA -$9.72M -$9.36M -$9.27M -$9.47M -$9.55M -$4.63M -$5.00M
Interest Income $19K $37K $44K $74K $95K $100K $117K
Income Before Tax -$9.72M -$9.34M -- -- -$10.06M -$5.22M --
Income Tax Expense -$13K $101K -- -- -$181K $61K --
Net Income -$9.71M -$9.44M -$9.24M -$8.89M -$9.88M -$5.28M -$4.71M
Basic EPS -$0.08 -$0.08 -$0.08 -- -$0.10 -$0.06 -$0.06
Diluted EPS -$0.08 -$0.08 -$0.08 -- -$0.10 -$0.06 -$0.06
Basic Shares Outstanding 127.9M 119.7M 112.3M -- 101.3M 91.0M 84.6M
Diluted Shares Outstanding 127.9M 119.7M 112.3M -- 101.3M 91.0M 84.6M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $5.20M $11.08M
Cash & Short-Term Investments $5.20M $11.08M
Total Current Assets $6.84M $12.44M
Property, Plant & Equipment, Net $228K $286K
Total Non-Current Assets $738K $985K
Total Assets $7.58M $13.42M
Accounts Payable $3.50M $756K
Other Current Liabilities $0 $1.12M
Total Current Liabilities $6.10M $4.88M
Deferred Revenue (Non-Current) $4.91M $4.68M
Total Non-Current Liabilities $5.28M $5.24M
Total Liabilities $11.38M $10.12M
Total Debt (incl. Leases) $563K $761K
Common Stock $0 $0
Retained Earnings -$429.5M -$400.7M
Accumulated Other Comp. Income $6.22M $6.36M
Total Stockholders' Equity -$3.80M $3.30M
Total Equity -$3.80M $3.30M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2024-12-31
Cash & Cash Equivalents $2.43M $4.12M $5.49M $5.20M $11.08M
Cash & Short-Term Investments $2.43M $4.12M $5.49M $5.20M $11.08M
Total Current Assets $5.27M $7.07M $7.49M $6.84M $12.44M
Property, Plant & Equipment, Net $193K $202K $218K $228K $286K
Total Non-Current Assets $558K $602K $674K $738K $985K
Total Assets $5.83M $7.67M $8.16M $7.58M $13.42M
Accounts Payable $3.21M $3.40M $2.68M $3.50M $756K
Other Current Liabilities -- -- -- $0 $1.12M
Total Current Liabilities $5.92M $5.22M $5.42M $6.10M $4.88M
Deferred Revenue (Non-Current) $4.91M $4.91M $4.91M $4.91M $4.68M
Total Non-Current Liabilities $7.42M $8.61M $7.87M $5.28M $5.24M
Total Liabilities $13.34M $13.84M $13.29M $11.38M $10.12M
Total Debt (incl. Leases) $410K $448K $508K $563K $761K
Common Stock $0 $0 $0 $0 $0
Retained Earnings -$457.9M -$448.2M -$438.7M -$429.5M -$400.7M
Accumulated Other Comp. Income $6.22M $6.22M $6.22M $6.22M $6.36M
Total Stockholders' Equity -$7.50M -$6.17M -$5.13M -$3.80M $3.30M
Total Equity -$7.50M -$6.17M -$5.13M -$3.80M $3.30M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31
Net Income -$28.76M -$22.79M
Depreciation & Amortization $70K $87K
Stock-Based Compensation $3.10M $1.98M
Change in Payables $2.93M $4.0K
Operating Cash Flow -$20.11M -$19.88M
Capital Expenditure -$6.0K -$174K
Free Cash Flow -$20.12M -$20.06M
Investing Cash Flow -$6.0K -$174K
Financing Cash Flow $14.12M $5.03M
Net Change in Cash -$5.88M -$15.32M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$9.71M -$9.44M -$9.24M -$8.89M -$9.88M -$5.28M -$4.71M
Depreciation & Amortization $17K $15K $16K $16K $17K $18K $19K
Stock-Based Compensation $1.29M $1.79M $2.30M $985K $912K $362K $845K
Change in Payables -$190K $730K -$813K $1.22M $1.36M $242K $112K
Operating Cash Flow -$6.92M -$8.14M -$7.29M -$6.43M -$4.84M -$4.11M -$4.73M
Capital Expenditure -$7.0K $0 -$6.0K -$1.0K -$4.0K $0 -$1.0K
Free Cash Flow -$6.92M -$8.14M -$7.30M -$6.43M -$4.85M -$4.11M -$4.73M
Investing Cash Flow -$7.0K $0 -$6.0K -$1.0K -$4.0K $0 -$1.0K
Common Stock Issued -- -- $7.61M -- -- -- $4.18M
Financing Cash Flow $5.24M $6.77M $7.61M $2.75M $3.09M $4.09M $4.18M
Net Change in Cash -$1.69M -$1.38M $291K -$3.67M -$1.85M $76K -$434K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31
Return on Equity (ROE) -- -691.1%
Return on Assets (ROA) -379.3% -169.8%
Current Ratio 1.12x 2.55x
Quick Ratio 0.85x 2.27x
Debt to Equity -- 0.23x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Return on Assets (ROA) -639.3% -488.3% -407.9% -379.3% -- -- --
Current Ratio 0.89x 1.35x 1.38x 1.12x -- -- --
Quick Ratio 0.41x 0.79x 1.01x 0.85x -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001129928) · from December 31, 2024 Data through September 30, 2026 · synced Nov 21, 2026, 05:00 UTC · Open in terminal